Depletion of intrinsic expression of Interleukin-8 in prostate cancer cells causes cell cycle arrest, spontaneous apoptosis and increases the efficacy of chemotherapeutic drugs

Molecular Cancer

Volumn 8, Issue , 2009, Pages

  Singh, Rajendra K ^a,b   Lokeshwar, Bal L ^a,b  

^a UNIVERSITY OF MIAMI   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; CASPASE 9; CYCLIN B1; CYCLIN D1; DOCETAXEL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; RAPAMYCIN; SMALL INTERFERING RNA; STAUROSPORINE; VASCULOTROPIN; ANTINEOPLASTIC AGENT; APOPTOSIS REGULATORY PROTEIN; RECOMBINANT PROTEIN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; CANCER CELL; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL MOTILITY; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG CYTOTOXICITY; DRUG SENSITIVITY; ENZYME ACTIVATION; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; HUMAN CELL; IC 50; PROSTATE CANCER; PROTEIN CLEAVAGE; PROTEIN DEPLETION; PROTEIN PROCESSING; RNA INTERFERENCE; TRANSIENT TRANSFECTION; BIOSYNTHESIS; CANCER INVASION; CELL CYCLE; CELL GROWTH; CELL MOTION; CHEMOTAXIS; DRUG EFFECT; GENE SILENCING; GENETICS; MALE; METABOLISM; METASTASIS; PATHOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL CYCLE; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; CHEMOTAXIS; GENE SILENCING; HUMANS; INTERLEUKIN-8; MALE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROSTATIC NEOPLASMS; RECOMBINANT PROTEINS; RNA, SMALL INTERFERING; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 69249182671     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-8-57     Document Type: Article

References (57)

1. Jemal A Siegel R Ward E Hao Y Xu J Murray T Thun MJ Cancer statistics CA Cancer J Clin 2008, 58(2):71-96. 10.3322/CA.2007.0010 18287387
2. Hadaschik BA Gleave ME Therapeutic options for hormone-refractory prostate cancer in 2007 Urol Oncol 2007, 25:413-9. 17826663
3. Lucas A Petrylak DP The case for early chemotherapy for the treatment of metastatic disease J Urol 2006, 176(6):S72-5. 10.1016/j.juro.2006.06.077 17084173
4. Haqqani AS Sandhu JK Birnboim HC Expression of Interleukin-8 promotes neutrophil infiltration and genetic instability in mutant tumors Neoplasia 2000, 2(6):561-68. 10.1038/sj.neo.7900110 1508092 11228549
5. Bischoff DS Zhu JH Makhijani NS Kumar A Yamaguchi DT Angiogenic CXC chemokine expression during differentiation of human mesenchymal stem cells towards the osteoblastic lineage J Cell Biochem 2008, 103:812-24. 10.1002/jcb.21450 17583554
6. Xie K Interleukin-8 and human cancer biology Cytokine Growth Factor Rev 2001, 12:375-91. 10.1016/S1359-6101(01)00016-8 11544106
7. Kunsch C Lang RK Rosen CA Shannon FM Synergistic transcriptional activation of the IL-8 gene by NF-KB p65 (RelA) and NF-11-6 J Immunol 1994, 153:1153-64.
8. Maxwell PJ Gallagher R Seaton A Wilson C Scullin P Pettigrew J Stratford IJ Williams KJ Johnston PG Waugh DJ HIF-1 and NF-k B-mediated upregulation of CXCR1 and CXCR2 expression promotes cell survival in hypoxic prostate cancer cells Oncogene 2007, 26:7333-7345. 10.1038/ sj.onc.1210536 17533374
9. Chavey C Mühlbauer M Bossard C Freund A Durand S Jorgensen C Jobin C Lazennec G Interleukin-8 expression is regulated by histone deacetylases through the NF-{kappa}B pathway in breast cancer Mol Pharmacol 2008, 74:1359-66. 10.1124/mol.108.047332 18669446
10. Kumar P Ning Y Polverini PJ Endothelial cells expressing Bcl-2 promote tumor metastasis by enhancing tumor angiogenesis, blood vessel leakiness and tumor invasion Lab Invest 2008, 88:740-49. 10.1038/labinvest.2008.46 18490895
11. Singh S Sadanandam A Singh RK Chemokines in tumor angiogenesis and metastasis Cancer Metastasis Rev 2007, 26:453-67. 10.1007/ s10555-007-9068-9 17828470
12. Kamohara H Takahashi M Ishiko T Ogawa M Baba H Induction of interleukin-8 (CXCL-8) by tumor necrosis factor-alpha and leukemia inhibitory factor in pancreatic carcinoma cells: Impact of CXCL-8 as an autocrine growth factor Int J Oncol 2007, 31:627-32. 17671691
13. Holmes WE Lee J Kuang WJ Rice GC Wood WI Structure and functional expression of a human interleukin-8 receptor Science 1991, 253:1278-80. 10.1126/science.1840701 1840701
14. Feniger-Barish R Belkin D Zaslaver A Gal S Dori M Ran M Ben-Baruch A GCP-2-induced internalization of IL-8 receptors: Hierarchical relationships between GCP-2 and other ELR1-CXC chemokines and mechanisms regulating CXCR2 internalization and recycling Blood 2000, 95:1551-59. 10688807
15. Allen SJ Crown SE Handel TM Chemokine: Receptor structure, interactions, and antagonism Annu Rev Immunol 2007, 25:787-820. 10.1146/ annurev.immunol.24.021605.090529 17291188
16. Tanaka T Bai Z Srinoulprasert Y Yang B Hayasaka H Miyasaka M Chemokines in tumor progression and metastasis Cancer Sci 2005, 96:317-22. 10.1111/ j.1349-7006.2005.00059.x 15958053
17. Moore BB Arenberg DA Stoy K Morgan T Addison CL Morris SB Glass M Wilke C Xue YY Sitterding S Kunkel SL Burdick MD Strieter RM Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells Am J Pathol 1999, 154:1503-12. 1866583 10329603
18. Murphy C McGurk M Pettigrew J Santinelli A Mazzucchelli R Johnston PG Montironi R Waugh DJ Nonapical and cytoplasmic expression of interleukin-8, CXCR1, and CXCR2 correlates with cell proliferation and microvessel density in prostate cancer Clin Cancer Res 2005, 11:4117-27. 10.1158/1078-0432.CCR-04-1518 15930347
19. Patel BJ Pantuck AJ Zisman A Tsui KH Paik SH Caliliw R Sheriff S Wu L deKernion JB Tso CL Belldegrun AS CL1-GFP: An androgen independent metastatic tumor model for prostate cancer J Urol 2000, 164(4):1420-5. 10.1016/S0022-5347(05)67210-2 10992426
20. Tso CL McBride WH Sun J Patel B Tsui KH Paik SH Gitlitz B Caliliw R van Ophoven A Wu L deKernion J Belldegrun A Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells Cancer J 2000, 6(4):220-33. 11038142
21. Araki S Omori Y Lyn D Singh RK Meinbach DM Sandman Y Lokeshwar VB Lokeshwar BL Interleukin-8 is a molecular determinant of androgen independence and progression in prostate cancer Cancer Res 2007, 67:6854-62. 10.1158/0008-5472.CAN-07-1162 17638896
22. Inoue K Slaton JW Eve BY Kim SJ Perrotte P Balbay MD Yano S Bar-Eli M Radinsky R Pettaway CA Dinney CP Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer Clin Cancer Res 2000, 6:2104-19. 10815938
23. Kim SJ Uehara H Karashima T Mccarty M Shih N Fidler IJ Expression of interleukin-8 correlates with angiogenesis, tumorigenicity, and metastasis of human prostate cancer cells implanted orthotopically in nude mice Neoplasia 2001, 3:33-42. 10.1038/sj.neo.7900124 1505029 11326314
24. MacManus CF Pettigrew J Seaton A Wilson C Maxwell PJ Berlingeri S Purcell C McGurk M Johnston PG Waugh DJ Interleukin-8 signaling promotes translational regulation of cyclin D in androgen-independent prostate cancer cells Mol Cancer Res 2007, 5:737-48. 10.1158/ 1541-7786.MCR-07-0032 17606477
25. Grant S Cotargetting survival signaling pathways in cancer J Clin Invest 2008, 118:3003-06. 10.1172/JCI36898E1 2518078 18725993
26. Karin M Nuclear factor-kappaB in cancer development and progression Nature 2006, 441:431-6. 10.1038/nature04870 16724054
27. Poirier GG Poly (ADP-ribosylation) and apoptosis Mol Cell Biochem 1999, 199(1-2):125-37. 10544961
28. Duriez PJ Shah GM Cleavage of poly(ADP-ribose) polymerase: A sensitive parameter to study cell death Biochem Cell Biol 1997, 75(4):337-49. 10.1139/bcb-75-4-337 9493956
29. Cohen GM Caspases: The executioners of apoptosis Biochem J 1997, 326(Pt 1):1-16. 1218630 9337844
30. Yamanaka K Rocchi P Miyake H Fazli L Vessella B Zangemeister-Wittke U Gleave ME A novel antisense oligonucleotide inhibiting several antiapoptotic Bcl-2 family members induces apoptosis and enhances chemosensitivity in androgen-independent human prostate cancer PC3 cells Mol Cancer Ther 2005, 4:1689-98. 10.1158/1535-7163.MCT-05-0064 16275990
31. Korsmeyer SJ Shutter JR Veis DJ Merry DE Oltvai ZN Bcl-2/Bax: A rheostat that regulates an anti-oxidant pathway and cell death Semin Cancer Biol 1993, 4(6):327-32. 8142617
32. Chipuk JE Green DR How do BCL-2 proteins induce mitochondrial outer membrane permeabilization? Trends Cell Biol 2008, 18(4):157-64. 10.1016/ j.tcb.2008.01.007 18314333
33. Adams JM Cory S Bcl-2-regulated apoptosis: Mechanism and therapeutic potential Curr Opin Immunol 2007, 19(5):488-96. 10.1016/ j.coi.2007.05.004 17629468
34. Galletti E Magnani M Renzulli ML Botta M Paclitaxel and docetaxel resistance: Molecular mechanisms and development of new generation taxanes Chem Med Chem 2007, 2(7):920-42. 17530726
35. Beyaert R Vanhaesebroeck B Heyninck K Boone E De Valck D Schulze-Osthoff K Haegeman G Van Roy F Fiers W Sensitization of tumor cells to tumor necrosis factor action by the protein kinase inhibitor staurosporine Cancer Res 1993, 53(11):2623-30. 8495426
36. Easton JB Houghton PJ mTOR and cancer therapy Oncogene 2006, 25(48):6436-46. 10.1038/sj.onc.1209886 17041628
37. Fan X Patera AC Pong-Kennedy A Deno G Gonsiorek W Manfra DJ Vassileva G Zeng M Jackson C Sullivan L Sharif-Rodriguez W Opdenakker G Van Damme J Hedrick JA Lundell D Lira SA Hipkin RW Murine CXCR1 is a functional receptor for GCP-2/CXCL6 and IL-8/CXCL8 J Biol Chem 2007 282 11658 66 10.1074/jbc.M607705200 17197447
38. Luppi F Longo AM de Boer WI Rabe KF Hiemstra PS Interleukin-8 stimulates cell proliferation in non-small cell lung cancer through epidermal growth factor receptor transactivation Lung Cancer 2007, 56:25-33. 10.1016/j.lungcan.2006.11.014 17175059
39. Takeyama K Mitsuzawa H Shimizu T Konishi M Nishitani C Sano H Kunishima Y Matsukawa M Takahashi S Shibata K Tsukamoto T Kuroki Y Prostate cell lines secrete IL-8 in response to Mycoplasma hominis through Toll-like receptor 2-mediated mechanism Prostate 2006, 66:386-91. 10.1002/ pros.20358 16302262
40. Pfitzenmaier J Vessella R Higano CS Noteboom JL Wallace D Jr Corey E Elevation of cytokine levels in cachectic patients with prostate carcinoma Cancer 2003, 97(5):1211-6. 10.1002/cncr.11178 12599227
41. Caruso DJ Carmack AJ Lokeshwar VB Duncan RC Soloway MS Lokeshwar BL Osteopontin and interleukin-8 expression is independently associated with prostate cancer recurrence Clin Cancer Res 2008, 14:4111-8. 10.1158/ 1078-0432.CCR-08-0738 2665724 18593988
42. Lindholm PF Bub J Kaul S Shidham VB Kajdacsy-Balla A The role of constitutive NF-kB activity in PC-3 human prostate cancer cell invasive behavior Clin Exp Metastasis 2001, 18:471-9. 10.1023/A:1011845725394
43. Wilson C Purcell C Seaton A Oladipo O Maxwell PJ O'Sullivan JM Wilson RH Johnston PG Waugh DJ Chemotherapy-induced CXC-chemokine/CXC-chemokine receptor signaling in metastatic prostate cancer cells confers resistance to oxaliplatin through potentiation of nuclear factor-kappaB transcription and evasion of apoptosis J Pharmacol Exp Ther 2008, 327:746-59. 10.1124/jpet.108.143826 18780829
44. Martin D Galisteo R Gutkind JS CXCL8/IL8 Stimulates Vascular Endothelial Growth Factor (VEGF) Expression and the Autocrine Activation of VEGFR2 in Endothelial Cells by Activating NF{kappa}B through the CBM (Carma3/ Bcl10/Malt1) Complex J Biol Chem 2009, 284:6038-42. 10.1074/ jbc.C800207200 19112107
45. Inou K Wood CG Slaton JW Karashima T Sweeney P Dinney CP Adenoviral-Mediated gene therapy of human bladder cancer with antisense interleukine-8 Oncol Rep 2001, 8:955-64. 11496299
46. Wang CY Mayo MW Korneluk RG Goeddel DV Baldwin AS Jr NF-kB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation Science 1998, 281:1680-3. 10.1126/ science.281.5383.1680 9733516
47. Wang CY Guttridge DC Mayo MW Baldwin AS Jr NF-kB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis Mol Cell Biol 1999, 19:5923-9. 84448 10454539
48. Cusack JC Liu R Baldwin AS NF-kB and chemoresistance: Potentiation of cancer drugs via inhibition of NF-kB Drug Resist Updat 1999, 2:271-3. 10.1054/drup.1999.0094 11504498
49. McDonnell TJ Troncoso P Brisbay SM Logothetis C Chung LW Hsieh JT Tu SM Campbell ML Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer Cancer Res 1992, 52:6940-4. 1458483
50. Apakama I Robinson MC Walter NM Charlton RG Royds JA Fuller CE Neal DE Hamdy FC bcl-2 overexpression combined with p53 protein accumulation correlates with hormone-refractory prostate cancer Br J Cancer 1996, 74:1258-62. 8883414
51. Colombel M Symmans F Gil S O'Toole KM Chopin D Benson M Olsson CA Korsmeyer S Buttyan R Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers Am J Pathol 1993, 143:390-400. 1887010 7688182
52. Seaton A Scullin P Maxwell PJ Wilson C Pettigrew J Gallagher R O'Sullivan JM Johnston PG Waugh DJ Interleukin-8 signaling promotes androgen-indpendent proliferation of prostate cancer cells via induction of androgen receptor expression and activation Carcinogenesis 2008, 29:1148-1156. 10.1093/carcin/bgn109 18487223
53. Karl E Warner K Zeitlin B Kaneko T Wurtzel L Jin T Chang J Wang S Wang CY Strieter RM Nunez G Polverini PJ Nör JE Bcl-2 acts in a proangiogenic signaling pathway through nuclear factor-kB and CXC chemokines Cancer Res 2005, 65:5063-5069. 10.1158/0008-5472.CAN-05-0140 15958549
54. Yamanaka K Rocchi P Miyake H Fazli L So A Zangemeister-Wittke U Gleave ME Induction of apoptosis and enhancement of chemosensitivity in human prostate cancer LNCaP cells using bispecific antisense oligonucleotide targeting Bcl-2 and Bcl-xL genes BJU Int 2006, 97:1300-08. 10.1111/ j.1464-410X.2006.06147.x 16686729
55. Veltri RW Miller MC Zhao G Ng A Marley GM Wright GL Jr Vessella RL Ralph D Interleukin-8 serum levels in patients with benign prostatic hyperplasia and prostate cancer Urology 1999, 53:139-47. 10.1016/ S0090-4295(98)00455-5 9886603
56. Lokeshwar BL Selzer MG Zhu BQ Block NL Golub LM Inhibition of cell proliferation, invasion, tumor growth and metastasis by an oral non-antimicrobial tetracycline analog (COL-3) in a metastatic prostate cancer model Int J Cancer 2002, 98:297-09. 10.1002/ijc.10168 11857423
57. Dandekar DS Lokeshwar BL Inhibition of cyclooxygenase (COX)-2 expression by Tet-inducible COX-2 antisense cDNA in hormone-refractory prostate cancer significantly slows tumor growth and improves efficacy of chemotherapeutic drugs Clin Cancer Res 2004, 10:8037-47. 10.1158/ 1078-0432.CCR-04-1208 15585639